Beijing: On July 25, China gave conditional approval to domestic firm Genuine Biotech’s Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against the coronavirus. The Azvudine tablet, which China approved in July last year to treat certain HIV-1 virus infections, has been given a conditional green light to treat adult patients with “normal type” COVID, the National Medical Products Administration said in a statement.
You May Also Like
Putin takes part in trials of nasal form of COVID vaccine
Moscow: Russian President Vladimir Putin proclaimed on Wednesday that he had partaken…
- Alina Hashmi
- November 24, 2021
PM Imran Khan congratulated the KPK government on the free treatment of more than 250 lac people.
PM Imran Khan in a tweet congratulated the Khyber Pakhtunkhwa government on…
- Sanniah Hassan
- July 3, 2021
NIH releases health measures against Covid-19
On Sunday, the National Institute of Health, Islamabad (NIH) advised strict adherence…
- Alina Hashmi
- July 31, 2022
NCOC announces reduction in Covid-19 restrictions
Islamabad: In NCO’s meeting presided over by head of the National Command…
- Alina Hashmi
- September 14, 2021